Summary

The early identification of diabetes and cardiovascular disease (CVD) is essential to establish prevention strategies, which should be based on total risk for CVD. In patients with diabetes and hypertension, the current evidence supports a treatment goal of 140.90 mmHg. Coronary artery bypass grafting surgery is the optimal revascularization strategy in patients with diabetes, based on data from the FREEDOM trial.

  • diabetes mellitus
  • cardiovascular disease
  • FREEDOM
  • coronary artery bypass grafting
  • coronary artery disease
  • percutaneous coronary intervention
  • myocardial infarction
  • hypertension
  • ACCORD
  • cardiology & cardiovascular medicine clinical trials
  • cardiometabolic disorder
View Full Text